All News about Veracyte Inc
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/10/Cathie-Wood--founder-of-Ark-Invest-.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240603031308/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: Veracyte Q4 Earnings
February 22, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Veracyte
February 21, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240522130721/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240515789405/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240507478547/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240506512666/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240422296304/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240422349293/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240416752482/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Cathie-Wood-Bitcoin_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Cathie-Wood_4.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240227639570/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/cathie-wood-bitcoin_5.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20240222312513/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
February 22, 2024
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240221354545/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20240208633506/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240206436508/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Completes Acquisition of C2i Genomics
February 06, 2024
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240108004593/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie-Wood-Ark-Invest_3.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231212272032/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231201811059/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20231129259153/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.